Cyproheptadine significantly improves the overall and progression-free survival of sorafenib-treated advanced HCC patients

OBJECTIVE: Sorafenib is a recommended treatment for advanced hepatocellular carcinoma. The study is to evaluate the efficacy of sorafenib plus cyproheptadine compared with sorafenib alone in patients with advanced hepatocellular carcinoma. METHODS: A retrospective cohort study reviewed all consecuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Yu-Min, Feng, Chin-Wen, Lu, Chin-Li, Lee, Ming-Yang, Chen, Chi-Yi, Chen, Solomon Chih-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376992/
https://www.ncbi.nlm.nih.gov/pubmed/25646358
http://dx.doi.org/10.1093/jjco/hyv007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376992/
https://www.ncbi.nlm.nih.gov/pubmed/25646358
http://dx.doi.org/10.1093/jjco/hyv007

Ejemplares similares